Benign pneumatosis intestinalis in a pediatric patient with multiple risk factors including granulomatosis with polyangiitis: A case report and review of the literature

Chang, Caroline Y.; Marzan, Katherine

doi:10.1016/j.semarthrit.2014.10.005

Cited by 11 publications

(5 citation statements)

References 63 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…3) Microbial theory: bacteria could penetrate the intestinal wall through increasing the mucosa permeability, decompose nutrients, and produce gas, which leads the development of pneumatosis (Young et al, 1996;Honne et al, 2010). 4) Intestinal mucosal vascular injury: antiangiogenic drug and microangiopathy disrupt the intestinal wall by necrosis of the serosa (Coriat et al, 2011;Chang and Marzan, 2015;Nakagawa et al, 2015).…”

Section: Discussionmentioning

confidence: 99%

Disputes and Challenges of Immune Checkpoint Inhibitors in Gastrointestinal Cancers

2024

Frontiers Research Topics

View full text Add to dashboard Cite

Frontiers is more than just an open access publisher of scholarly articles: it is a pioneering approach to the world of academia, radically improving the way scholarly research is managed. The grand vision of Frontiers is a world where all people have an equal opportunity to seek, share and generate knowledge. Frontiers provides immediate and permanent online open access to all its publications, but this alone is not enough to realize our grand goals. Frontiers journal seriesThe Frontiers journal series is a multi-tier and interdisciplinary set of openaccess, online journals, promising a paradigm shift from the current review, selection and dissemination processes in academic publishing. All Frontiers journals are driven by researchers for researchers; therefore, they constitute a service to the scholarly community. At the same time, the Frontiers journal series operates on a revolutionary invention, the tiered publishing system, initially addressing specific communities of scholars, and gradually climbing up to broader public understanding, thus serving the interests of the lay society, too. Dedication to qualityEach Frontiers article is a landmark of the highest quality, thanks to genuinely collaborative interactions between authors and review editors, who include some of the world's best academicians. Research must be certified by peers before entering a stream of knowledge that may eventually reach the public -and shape society; therefore, Frontiers only applies the most rigorous and unbiased reviews. Frontiers revolutionizes research publishing by freely delivering the most outstanding research, evaluated with no bias from both the academic and social point of view. By applying the most advanced information technologies, Frontiers is catapulting scholarly publishing into a new generation. What are Frontiers Research Topics?Frontiers Research Topics are very popular trademarks of the Frontiers journals series: they are collections of at least ten articles, all centered on a particular subject. With their unique mix of varied contributions from Original Research to Review Articles, Frontiers Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area.

show abstract

Section: Discussionmentioning

confidence: 99%

Disputes and Challenges of Immune Checkpoint Inhibitors in Gastrointestinal Cancers

2024

Frontiers Research Topics

View full text Add to dashboard Cite

show abstract

“…3) Microbial theory: bacteria could penetrate the intestinal wall through increasing the mucosa permeability, decompose nutrients, and produce gas, which leads the development of pneumatosis ( Young et al, 1996 ; Honne et al, 2010 ). 4) Intestinal mucosal vascular injury: antiangiogenic drug and microangiopathy disrupt the intestinal wall by necrosis of the serosa ( Coriat et al, 2011 ; Chang and Marzan, 2015 ; Nakagawa et al, 2015 ).…”

Section: Discussionmentioning

confidence: 99%

Pneumatosis intestinalis post steroid use in a patient with immune-related adverse events: Case report, literature review and FAERS analysis

et al. 2023

View full text Add to dashboard Cite

Introduction: The accurate diagnosis of pneumatosis intestinalis (PI) is increasing despite patients’ limited identification of etiologic factors. Recently a patient with lung squamous carcinoma who developed pneumatosis intestinalis following methylprednisolone administration for immune-related adverse events was treated at our hospital. Subsequent a literature review and an analysis of the FDA Adverse Event Reporting System (FAERS) database enabled the identification of additional cases of pneumatosis intestinalis.Methods: A literature review of the MEDLINE/PubMed and Web of Science Core Collection databases using standard pneumatosis intestinalis search terms to identify published cases of immune checkpoint inhibitors (ICIs) or steroids causing pneumatosis intestinalis were performed. A separate retrospective pharmacovigilance study of FAERS enabled the extraction of unpublished cases of pneumatosis intestinalis between the first quarter of 2005 and the third quarter of 2022. Disproportionality and Bayesian analyses were performed to identify signal detection in reported odds ratios, proportional reporting ratios, information components, and empirical Bayesian geometric means.Results: Ten case reports of steroid-related pneumatosis intestinalis were retrieved from six published studies. The implicated drug therapies included pre-treatment with steroids before chemotherapy, combination therapy with cytotoxic agents and steroids, and monotherapy with steroids. In the FAERS pharmacovigilance study, 1,272 cases of immune checkpoint inhibitors or steroid-related pneumatosis intestinalis were incidentally reported. The signal detected in five kinds of immune checkpoint inhibitors and six kinds of steroids implied a positive correlation between the drugs and adverse events.Conclusion: Steroids might be the etiologic factors in the current case of pneumatosis intestinalis. Reports supporting the role of steroids in suspected cases of pneumatosis intestinalis can be found in literature databases and the FAERS database. Even so, as documented in FAERS, immune checkpoint inhibitors-induced pneumatosis intestinalis should not be excluded.

show abstract

“…PCI was first recorded by Duvernoi at an autopsy in 1730 ( 21 ). PCI can occur in many autoimmune diseases, such as systemic sclerosis (SSc) and systemic lupus erythematosus (SLE) ( 22 ). However, few articles have reported PCI in DM.…”

Section: Discussionmentioning

confidence: 99%

Pneumatosis cystoides intestinalis in dermatomyositis: a case series report and literature review

Zhang

Lü

2023

Front. Immunol.

View full text Add to dashboard Cite

Pneumatosis cystoides intestinalis (PCI) in adult dermatomyositis (DM) is rarely described. This report aimed to describe the clinical features and prognosis of PCI in six adult patients with DM (four with anti-MDA5 antibodies, one with anti-SAE antibodies, and one with anti-TIF-1γ antibodies). Except for one patient with transient abdominal pain, the remaining five patients were asymptomatic. PCI occurred in the ascending colon in all patients, of whom five had free gas in the abdominal cavity. No patients received excessive treatment, and PCI disappeared in four patients during the follow-up. Additionally, we reviewed previous studies on this complication.

show abstract

Benign pneumatosis intestinalis in a pediatric patient with multiple risk factors including granulomatosis with polyangiitis: A case report and review of the literature

Cited by 11 publications

References 63 publications

Disputes and Challenges of Immune Checkpoint Inhibitors in Gastrointestinal Cancers

Disputes and Challenges of Immune Checkpoint Inhibitors in Gastrointestinal Cancers

Pneumatosis intestinalis post steroid use in a patient with immune-related adverse events: Case report, literature review and FAERS analysis

Pneumatosis cystoides intestinalis in dermatomyositis: a case series report and literature review

Contact Info

Product

Resources

About